Skip to Main Content
 
Capabilities

Virtus Successfully Defends Drug Marketing in ITC

 
September 27, 2018

Related Industry:

Life Sciences
 
Case Study

Husch Blackwell litigators successfully defended Virtus Pharmaceuticals against a competitor’s claim that Virtus unfairly marketed one of its generic drugs. After opening statements at the U.S. International Trade Commission (ITC), the judge told the competitor that Virtus’ prehearing submissions were so persuasive that he was unlikely to rule in the competitor’s favor. The competitor withdrew its complaint, allowing patients continued access to Virtus’ lower-priced drug.

Professionals:

Don J. Mizerk

Partner

David Gerasimow

Associate

Laurie A. Haynie

Senior Counsel

Beau Jackson

Partner

Melissa McGinn

Paralegal Assistant

Frank E. Norton

Senior Paralegal